Digital PCR & Real-Time PCR Market by Type (dPCR, qPCR), Product Type (Instruments, Reagents and Consumables, Services), Application - Global Forecast 2023-2030
The Digital PCR & Real-Time PCR Market size was estimated at USD 7.93 billion in 2022 and expected to reach USD 8.70 billion in 2023, at a CAGR 10.01% to reach USD 17.04 billion by 2030 .
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Digital PCR & Real-Time PCR Market.
- Based on Type, market is studied across dPCR and qPCR. The dPCR commanded largest market share of 65.72% in 2022, followed by qPCR.
- Based on Product Type, market is studied across Instruments, Reagents and Consumables, and Services. The Instruments commanded largest market share of 51.45% in 2022, followed by Reagents and Consumables.
- Based on Application, market is studied across Clinical Research, Forensic Labs, and Research Institutes. The Clinical Research commanded largest market share of 62.82% in 2022, followed by Forensic Labs.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 41.25% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Digital PCR & Real-Time PCR Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Digital PCR & Real-Time PCR Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Digital PCR & Real-Time PCR Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Inc., Agilent Technologies, Inc., Analytik Jena GmbH+Co. KG, Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocompare by CompareNetworks, Inc., BIOMÉRIEUX S.A., Bioneer Corporation, Danaher Corporation, ELITech Group, Enzo Life Sciences, Inc., Eppendorf SE, Etcon Analytical and Environmental Systems & Services Ltd., Explorea s.r.o, F. Hoffmann-La Roche AG, Global Engage Sdn. Bhd., Hangzhou Longgene Scientific Instruments Co., Ltd., Heal Force Bio-Meditech Holdings Limited, Integrated DNA Technologies, Inc., LABGENE Scientific SA, Merck KGaA, Meridian Bioscience, Inc., Promega Corporation, QIAGEN N.V., Quidel Corporation, R-Biopharm AG, RainSure Scientific, Roche Diagnostics Corporation, Solis BioDyne OÜ, STANDARD BIOTOOLS INC., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp.
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Digital PCR & Real-Time PCR Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Digital PCR & Real-Time PCR Market?
- What is the competitive strategic window for identifying opportunities in the Digital PCR & Real-Time PCR Market?
- What are the latest technology trends and regulatory frameworks in the Digital PCR & Real-Time PCR Market?
- What is the market share of the leading vendors in the Digital PCR & Real-Time PCR Market?
- Which modes and strategic moves are suitable for entering the Digital PCR & Real-Time PCR Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Digital PCR & Real-Time PCR Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Potential benefits of dPCR & qPCR for clinical virology diagnostics
- 5.1.1.2. Increasing incidences of genetic and infectious diseases
- 5.1.1.3. Emerging applications of dPCR & qPCR in biomarker discovery
- 5.1.2. Restraints
- 5.1.2.1. Cost related to development of dPCR & qPCR devices
- 5.1.3. Opportunities
- 5.1.3.1. Emergence of droplet digital PCR (ddPCR) technology
- 5.1.3.2. Conveyance from plant-derived to the development of herbal genomics-based drug discovery
- 5.1.4. Challenges
- 5.1.4.1. Limitations associated with dPCR & qPCR techniques
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Digital PCR & Real-Time PCR Market, by Type
- 6.1. Introduction
- 6.2. dPCR
- 6.3. qPCR
- 7. Digital PCR & Real-Time PCR Market, by Product Type
- 7.1. Introduction
- 7.2. Instruments
- 7.3. Reagents and Consumables
- 7.4. Services
- 8. Digital PCR & Real-Time PCR Market, by Application
- 8.1. Introduction
- 8.2. Clinical Research
- 8.3. Forensic Labs
- 8.4. Research Institutes
- 9. Americas Digital PCR & Real-Time PCR Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Digital PCR & Real-Time PCR Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Digital PCR & Real-Time PCR Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Agreement, Collaboration, & Partnership
- 12.3.1.1. Oncological Digital PCR kits to launch after Stilla and Atila cooperation
- 12.3.1.2. QIAGEN Strengthens growing portfolio of applications for its digital PCR platform qiacuity with new collaborations
- 12.3.2. New Product Launch & Enhancement
- 12.3.2.1. Thermo Fisher Scientific launches new digital PCR automation solution
- 12.3.2.2. Roche launches a digital PCR system, a powerful new diagnostics platform in the fight against cancer and other diseases
- 12.3.2.3. Cipla launches real time RT-PCR test kit for COVID-19
- 12.3.3. Award, Recognition, & Expansion
- 12.3.3.1. Roche expands the COVID-19 PCR test portfolio to the new cobas 5800 System in countries accepting the CE Mark
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories, Inc.
- 13.1.2. Agilent Technologies, Inc.
- 13.1.3. Analytik Jena GmbH+Co. KG
- 13.1.4. Azure Biosystems Inc.
- 13.1.5. Becton, Dickinson and Company
- 13.1.6. Bio-Rad Laboratories, Inc.
- 13.1.7. Biocompare by CompareNetworks, Inc.
- 13.1.8. BIOMÉRIEUX S.A.
- 13.1.9. Bioneer Corporation
- 13.1.10. Danaher Corporation
- 13.1.11. ELITech Group
- 13.1.12. Enzo Life Sciences, Inc.
- 13.1.13. Eppendorf SE
- 13.1.14. Etcon Analytical and Environmental Systems & Services Ltd.
- 13.1.15. Explorea s.r.o
- 13.1.16. F. Hoffmann-La Roche AG
- 13.1.17. Global Engage Sdn. Bhd.
- 13.1.18. Hangzhou Longgene Scientific Instruments Co., Ltd.
- 13.1.19. Heal Force Bio-Meditech Holdings Limited
- 13.1.20. Integrated DNA Technologies, Inc.
- 13.1.21. LABGENE Scientific SA
- 13.1.22. Merck KGaA
- 13.1.23. Meridian Bioscience, Inc.
- 13.1.24. Promega Corporation
- 13.1.25. QIAGEN N.V.
- 13.1.26. Quidel Corporation
- 13.1.27. R-Biopharm AG
- 13.1.28. RainSure Scientific
- 13.1.29. Roche Diagnostics Corporation
- 13.1.30. Solis BioDyne OÜ
- 13.1.31. STANDARD BIOTOOLS INC.
- 13.1.32. Takara Bio USA, Inc.
- 13.1.33. Thermo Fisher Scientific Inc.
- 13.1.34. Zymo Research Corp
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook